cardiac sarcoidosis: thinning of the basal septum in the setting of extracardiac sarcoidosis carries a high specificity for cardiac involvement. mdpi.com/2075-1729/13/8…

Final clap for #CVCT2024 ! Thank you for 3 days of deep scientific discussions, inspiration and friendship ! Now, time for action ! #clinicaltrials #movingforward

🎉Graduation day is here! 🎓 Huge congrats to everyone who will be celebrating and taking their next steps towards careers in #GlobalHealth.🌍👩‍🎓👨‍🎓 Don't forget to tag us in your #LSHTMGrad posts📸

Edinburgh, Scotland 🏴󠁧󠁢󠁳󠁣󠁴󠁿 📸: John Murray Jnr

🌍 EACVI VHD-W Registry 🌍 30+ centers worldwide 👩‍⚕️ Largest registry on gender disparities in VHD 📅 Site enrolment deadline: 30 April 2025 🔎 Help shape future care! 🚀Join us! [email protected] EACVI President Victoria Delgado Julia Grapsa José F. Rodríguez Palomares

#EHJCVI 🧬 Curious how multimodality cardiac imaging helps in Anderson–Fabry disease? What are the gender differences? 🚻 How should we diagnose cardiac involvement? 🧪 How can we monitor treatment response? 📈 Learn more 👉 doi.org/10.1093/ehjci/…

Cuatro momentazos frente al Teide.

Heart disease is still the #1 killer in the United States, but it's no longer from heart attacks...instead it's from heart failure and arrhythmias ahajournals.org/doi/10.1161/JA…

In a few weeks, cardiology professionals will gather at #ESCCongress 2025 with #WCCardio for an unforgettable experience. Enjoy networking opportunities, celebrations, entertainment, CV health checks, & so much more. See what’s waiting in Madrid & register by 31 July to save

A novel paradigm to tackle ASCVD: personalized prevention guided by imaging detected silent atherosclerosis. The REACT initiative: early cure of atherosclerosis through precision prevention academic.oup.com/eurheartj/arti…

📌 En 3 días comienza #ESCCongress en Madrid 📑 ¿A qué tengo que estar atento? ✅Creo que vamos a contestar, y es ⬆️ importante, la 🙋‍♂️ de si hay beneficio rutinario de BB post-infarto🫀 con FEVI preservada: ➡️REBOOT (Borja Ibanez Xavier Rosselló) 🇪🇸 ➡️BETAMI 🇳🇴 ➡️DANBLOCK 🇩🇰

🔬#CNICatESCCongress 👉 A new analysis of the REBOOT trial trial, coordinated by CNIC and presented at the #ESCCongress of European Society of Cardiology, reveals gender differences in the effects of #betablockers after a #heartattack. In addition, women had a worse cardiovascular profile.

Very proud of this great team! Thanks Borja Ibanez and Xavier Rosselló for your leadership and for making this possible CNIC

Multidomain Rehabilitation for Older Patients with Myocardial Infarction: NEJM 🥸 Very important trial for older adults with frailty after AMI admissions: #ESCCongress2025 👇👇👇

Original Article: Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction (REBOOT trial) nej.md/45QYbws #ESCCongress | European Society of Cardiology

"This bold new framework helps to identify the true cause of HFpEF in most people…& should make an enormous difference in guiding effective treatment,” says Dr. Milton Packer on his Adipokine Hypothesis pub in JACC Journals. #ESCCongress #JACC #JACCHF bit.ly/4oZVcKN

Welcoming His Majesty King Felipe VI was a very special way to close our Congress and celebrate 75 years of the European Society of Cardiology. We were honored by His Majesty’s presence and hope that his words will raise awareness that cardiovascular disease is the world’s

Seven Sisters Cliffs

Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial. Just published in #EHJ #ESCCongress European Society of Cardiology European Society of Cardiology Journals #myocardialinfarction academic.oup.com/eurheartj/adva…

Scotland in Autumn🤎🍂